Under the auspices of the King Fahd bin Abdulaziz Al Saud Scientific Chair for Medical Biotechnology, Arabian Gulf University (AGU) hosted a scientific forum titled "The Future of Biotechnology: Unleashing the Latent Potential" at Prince Sultan bin Abdulaziz Al Saud Hall, located at the university’s campus. The event was attended by faculty members, researchers, and graduate students.

The forum commenced with a keynote speech by Professor Abdel Halim Deifalla, Dean of the College of Medicine and Health Sciences, who highlighted the significance of biotechnology and its expanding role in advancing diagnostic and therapeutic methods. He reaffirmed the university’s commitment to providing high-quality scientific platforms for discussion and development.

Professor Mai Sater, Supervisor of the King Fahd Chair for Medical Biotechnology, explained that the forum addressed key topics in medical biotechnology, including mRNA-based therapies, CRISPR gene editing technology, and the integration of AI in biotechnology and drug discovery. She also discussed ethical considerations linked to the rapid advancements in this vital sector. This event marks a step toward organising more specialised and in-depth scientific conferences across various biotechnology disciplines.

The forum featured a series of presentations by both local and international experts, focusing on innovative applications of biotechnology in medicine and public health. These began with a lecture by Professor Roland Brock, Professor of Biochemistry at Radboud University, Netherlands, and Adjunct Professor at AGU. He discussed applications of mRNA in immunity and cancer treatment, exploring its potential in designing novel vaccines and targeted therapies.

Professor Wael El Moslimany from the Centre for Environmental and Biological Studies discussed the role of microorganisms in promoting sustainable solutions for environmental and medical challenges. Dr Noureddine Ben Khalaf, Associate Professor of Molecular Medicine, examined how AI is revolutionising drug discovery processes. Dr Sebastian Taurin, Head of the Department of Molecular Medicine, discussed future prospects of CRISPR technology in medicine, highlighting its potential in treating hereditary and incurable diseases. Meanwhile, Dr Christina Skrypnyk, Assistant Professor in the Department of Molecular Medicine, addressed the ethical standards necessary for gene and AI-enhanced therapies.

The forum concluded with an open discussion titled "The Future of Biotechnology in the GCC: Opportunities and Ethical Considerations," where participants spotlighted the importance of research collaboration and called for the development of legislative and ethical frameworks to keep abreast of innovation.

This event aligns with AGU’s ongoing efforts to promote scientific dialogue and expand knowledge in biotechnology, as a key driver of progress in the healthcare and research sectors in the region.